Location History:
- Oakland, CA (US) (2001 - 2016)
- Bridgewater, NJ (US) (2021)
Company Filing History:
Years Active: 2001-2021
Title: The Innovations of Richard T Surosky
Introduction
Richard T Surosky is a notable inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of adeno-associated virus (AAV) virions. With a total of 4 patents, his work has advanced the understanding and application of viral vectors in gene therapy.
Latest Patents
One of Richard's latest patents focuses on AAV virions with decreased immunoreactivity. This patent describes methods of making and using recombinant AAV virions that include mutated capsid proteins or are derived from non-primate mammalian AAV serotypes. These innovations display decreased immunoreactivity relative to AAV-2, which is crucial for improving the efficacy of gene therapy applications.
Career Highlights
Throughout his career, Richard has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Genzyme Corporation and Avigen, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Richard has collaborated with several talented individuals, including Alejandra Elena Arbetman and Peter C Colosi. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Richard T Surosky's contributions to biotechnology, particularly in the realm of AAV virions, highlight his role as a significant inventor in the field. His work continues to influence advancements in gene therapy and related applications.